لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Castenmiller SM; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kanagasabesan N; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.; Oncode Institute, Utrecht, The Netherlands., Guislain A; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.; Oncode Institute, Utrecht, The Netherlands., Nicolet BP; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Loenen MM; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Veenhof AAFA; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands.; Department of Pulmonology, Leiden University Medical Center (LUMC), Leiden, The Netherlands., Hartemink KJ; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Haanen JBAG; Division of Medical Oncology and Division of Molecular Oncology and Immunology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.; Head of Melanoma Clinic, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., de Groot R; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.; Department of Hematology, LUMC, Leiden, The Netherlands., Wolkers MC; Sanquin Blood Supply, Division Research Immunotherapy, and Landsteiner Laboratory and Department of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.; Oncode Institute, Utrecht, The Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Aug 22; Vol. 13 (1), pp. 2392898. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/immunology , Lung Neoplasms*/pathology , Tertiary Lymphoid Structures*/immunology , Tertiary Lymphoid Structures*/pathology , Lymphocytes, Tumor-Infiltrating*/immunology, Humans ; Immunotherapy, Adoptive/methods ; Female ; Male ; B-Lymphocytes/immunology ; B-Lymphocytes/pathology ; Middle Aged ; Aged

المؤلفون: Morton LT; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Wachsmann TLA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Meeuwsen MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Wouters AK; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Remst DFG; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Loenen MM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Heemskerk MHM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands m.h.m.heemskerk@lumc.nl.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma* , Tumor Escape*, Histocompatibility Antigens Class I ; Humans ; Killer Cells, Natural ; Receptors, Antigen, T-Cell/genetics

المؤلفون: Strijker JGM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Pscheid R; Gadeta B.V., 3584 CM Utrecht, The Netherlands., Drent E; Gadeta B.V., 3584 CM Utrecht, The Netherlands., van der Hoek JJF; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Ober K; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van Hooff SR; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Coomans C; Gadeta B.V., 3584 CM Utrecht, The Netherlands., Bisso A; Gadeta B.V., 3584 CM Utrecht, The Netherlands., van Loenen MM; Gadeta B.V., 3584 CM Utrecht, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Wienke J; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

المصدر: Journal of personalized medicine [J Pers Med] 2021 Sep 17; Vol. 11 (9). Date of Electronic Publication: 2021 Sep 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE

المؤلفون: van Asten SD; Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Groot R; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Loenen MM; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Castenmiller SM; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Jong J; Department Of Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Monkhorst K; Department Of Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Haanen JBAG; Department Of Medical Oncology, NKI-AvL, Amsterdam, The Netherlands., Amsen D; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Bex A; Department Of Urology, NKI-AvL, Amsterdam, The Netherlands.; UCL Division of Surgery and Interventional Science, Royal Free London NHS Foundation Trust, London, UK., Spaapen RM; Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Wolkers MC; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2021 Jan 21; Vol. 10 (1), pp. 1860482. Date of Electronic Publication: 2021 Jan 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell* , Kidney Neoplasms*, CD8-Positive T-Lymphocytes ; Cytotoxicity, Immunologic ; Humans ; Interleukin-2 ; Lymphocytes, Tumor-Infiltrating ; Tumor Necrosis Factor Receptor Superfamily, Member 9

المؤلفون: van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Jedema I; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van Loenen MM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., de Boer R; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van Egmond HM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Hagedoorn RS; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Hoogstaten C; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Veld SAJ; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Hageman L; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van Liempt PAG; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Zwaginga JJ; Center for Clinical Transfusion Research, Sanquin Research, Leiden, Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands., Meij P; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., Heemskerk MHM; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

المصدر: Frontiers in immunology [Front Immunol] 2020 Aug 20; Vol. 11, pp. 1804. Date of Electronic Publication: 2020 Aug 20 (Print Publication: 2020).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Leukemia Effect* , Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/mortality, Graft vs Host Disease/*therapy , Hematopoietic Stem Cell Transplantation/*adverse effects , Herpesvirus 4, Human/*immunology , Leukemia/*surgery , Minor Histocompatibility Antigens/*immunology , Oligopeptides/*immunology , Receptors, Chimeric Antigen/*immunology , T-Lymphocytes/*transplantation, Adult ; Aged ; Female ; Graft vs Host Disease/genetics ; Graft vs Host Disease/immunology ; Graft vs Host Disease/metabolism ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Leukemia/genetics ; Leukemia/immunology ; Leukemia/metabolism ; Male ; Middle Aged ; Minor Histocompatibility Antigens/genetics ; Minor Histocompatibility Antigens/metabolism ; Netherlands ; Oligopeptides/genetics ; Oligopeptides/metabolism ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; T-Lymphocytes/virology ; Time Factors ; Transplantation, Homologous ; Treatment Outcome

المؤلفون: De Groot R; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, Netherlands., Van Loenen MM; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Guislain A; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, Netherlands., Nicolet BP; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, Netherlands., Freen-Van Heeren JJ; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, Netherlands., Verhagen OJHM; Department of Immunohematology, Sanquin Research, Amsterdam, The Netherlands., Van Den Heuvel MM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., De Jong J; Department of Pathology, (NKI-AvL), Amsterdam, The Netherlands., Burger P; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Laboratory of Cell Therapy, Sanquin Research, Amsterdam, The Netherlands., Van Der Schoot CE; Department of Immunohematology, Sanquin Research, Amsterdam, The Netherlands., Spaapen RM; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.; Department of Immunopathology, (NKI-AvL), Amsterdam, The Netherlands., Amsen D; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Monkhorst K; Department of Pathology, (NKI-AvL), Amsterdam, The Netherlands., Hartemink KJ; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands., Wolkers MC; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2019 Aug 15; Vol. 8 (11), pp. e1648170. Date of Electronic Publication: 2019 Aug 15 (Print Publication: 2019).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

المؤلفون: Flinsenberg TW; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Spel L; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Jansen M; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Koning D; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., de Haar C; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Plantinga M; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Scholman R; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., van Loenen MM; Laboratory of Hematology, University Medical Centre Leiden, Leiden, The Netherlands., Nierkens S; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Boon L; Bioceros BV, Utrecht, The Netherlands., van Baarle D; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Heemskerk MH; Laboratory of Hematology, University Medical Centre Leiden, Leiden, The Netherlands., Boelens JJ; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Boes M; Laboratory of Translational Immunology, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands mboes@umcutrecht.nl.

المصدر: Journal of virology [J Virol] 2015 Jan 15; Vol. 89 (2), pp. 1058-69. Date of Electronic Publication: 2014 Nov 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

مواضيع طبية MeSH: Cord Blood Stem Cell Transplantation* , Virus Activation*, CD4-Positive T-Lymphocytes/*immunology , CD8-Positive T-Lymphocytes/*immunology , Cytomegalovirus/*immunology , Cytomegalovirus/*physiology , Dendritic Cells/*immunology, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Interferon-gamma/metabolism ; Male ; Phosphoproteins/immunology ; Viral Matrix Proteins/immunology

المؤلفون: van Loenen MM; M.M.van_Loenen@lumc.nl., de Boer R, van Liempt E, Meij P, Jedema I, Falkenburg JH, Heemskerk MH

المصدر: Haematologica [Haematologica] 2014 Apr; Vol. 99 (4), pp. 759-68. Date of Electronic Publication: 2013 Dec 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Batch Cell Culture Techniques/*methods , Batch Cell Culture Techniques/*standards , T-Cell Antigen Receptor Specificity/*immunology , T-Lymphocytes/*immunology , T-Lymphocytes/*transplantation , Viruses/*immunology, Adoptive Transfer ; Histocompatibility Antigens Class I/chemistry ; Histocompatibility Antigens Class I/immunology ; Humans ; Immunomagnetic Separation ; Leukemia/immunology ; Leukemia/therapy ; Lymphocyte Activation ; Minor Histocompatibility Antigens/immunology ; Oligopeptides/immunology ; Peptides/chemistry ; Peptides/immunology ; Receptors, Antigen, T-Cell/immunology ; Transduction, Genetic